Kula Bio
PrivateLast Round
Series A
Extension
Nov 3, 2025
Total Funding Raised
$109.15M
Company Overview
Kula Bio operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Series A Extension round in November 2025.
Kula Bio is an agricultural biotechnology company that develops innovative biofertilizers aimed at providing affordable, organic, and sustainable fertilization solutions through the use of energy-rich soil microbes and advanced production technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kula Bio Comparables
Compare Kula Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azotic Technologies Limited | 84% | |
| Switch Bioworks | 83% | |
| Puna Bio | 81% |
For institutional investors. Book with your work email.
Kula Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 3, 2025 | ||||
| Series A Extension | Nov 20, 2023 | ||||
| Series A | Jan 27, 2022 | ||||
| Seed | May 25, 2021 | ||||
| Seed | Aug 3, 2020 | ||||
Seed | Oct 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kula Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iSelect Fund | Seed, Series A |
| Bopu Capital Management | Seed, Series A |
| Embark Ventures | Seed, Series A |
| The Nature Conservancy | Seed |
| The Grantham Foundation for the Protection of the Environment | Seed, Series A |
| Collaborative Fund | Series A, Seed |
| ACRE | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Launched Kula-NextSP, a shelf-stable, soluble powder for nitrogen-fixing bacteria.
- Feb 2, 2026
Kula-NSP, a shelf-stable nitrogen-fixing bacteria powder, has been commercially launched.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 15, 2026
Kula Bio, Inc. raises $86.7M across six funding rounds, including its largest round, a Series A in Jan '22.
For institutional investors. Book with your work email.
Kula Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kula Bio's valuation, stock price, and market status.
Is Kula Bio a public or private company?
Kula Bio is a private company.
What is the current stock price of Kula Bio?
Kula Bio is a private company, so its shares have no public market price. Caplight tracks Kula Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kula Bio worth (valuation)?
Valuation information for Kula Bio is not publicly available.
Can I buy Kula Bio stock?
Kula Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kula Bio's last funding round?
Kula Bio's most recent funding round was Series A Extension on November 3, 2025.
Who are the main investors in Kula Bio?
Key investors in Kula Bio include Collaborative Fund, Lowercarbon Capital.
Will Kula Bio IPO soon?
No public IPO plans have been announced for Kula Bio.
How can I track Kula Bio secondary market activity?
Caplight tracks bids, offers, and trades in Kula Bio's shares on secondary markets.